TORNTPHARMNSETORRENT PHARMACEUTICALS L· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 30 Jul, 2026 · 17:02 IST

Three Torrent Pharma senior managers exit amid reporting structure change

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+5.1%Reaction day
₹4890.00
prior close
₹4948.00
announcement price
After-mkt
timing
Nifty 100market+0.5%+4.6% vs market
Pharmaceuticals peers, median of 164sector+0.1%+5.0% vs sector

On the reaction day the stock moved 4.6 pts more than Nifty 100 and 5.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.5
10m
-0.7
15m
-0.4
30m
-0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+5.1+0.5+4.6+0.1+5.0
Next day
+3.3+2.0+1.3+1.1+2.2
2d
+2.9+1.4+1.5+1.0+1.8
3d
+2.0+1.5+0.6+1.1+1.0
4d
+1.3+1.5-0.2+1.2+0.2
5d
+1.2+1.4-0.2+1.5-0.3
1w
-0.1+1.0-1.2+2.3-2.4
15d
+0.1+0.1+0.0+1.3-1.2
1m
+3.6-0.5+4.1+2.0+1.6
2m
-1.8-6.4+4.6+3.2-5.0
3m
—————
UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Torrent Pharmaceuticals has informed exchanges that three Senior Management Personnel (SMPs), namely Hasmukh Patel, Sushil Jaiswal, and Sunil Nadkarni, have ceased to be part of SMP effective close of business hours on July 30, 2026. The reason cited is a change in reporting structure. The disclosure was filed under SEBI LODR Regulation 30. No replacement names or further details were provided in the filing.

Likely market impact

Looks like routine internal restructuring. Investors may seek clarity on whether this signals broader organisational change or leadership churn at the pharma major.